Moreover, ACTG1 expression has been reported to be correlated with the Montreal Cognitive Assessment score for AD patients and has been found to be associated with reduced levels in the blood and brain tissue of mice with AD 45. This evidence concerns the gene ACTG1 and Alzheimer disease.